Loading clinical trials...

A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT05167825

A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

The purpose of this study is to evaluate the effect of macitentan on hemodynamic measures at Week 24 in pediatric populations.

Lead sponsor: Janssen Pharmaceutical K.K.•11 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029 · Pulmonary Arterial Hypertension

RECRUITINGPhase 3

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

NCT07365332 · Pulmonary Arterial Hypertension

RECRUITINGPhase 1/2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension

RECRUITINGNA

Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension

NCT07120789 · Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), and more

RECRUITINGNA

AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension?

NCT07457762 · Pulmonary Arterial Hypertension (PAH)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 21, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment7

Start dateNov 2022

Last updatedOct 21, 2025

Condition

Pulmonary Arterial Hypertension

Locations shown

Nagano Children's Hospital

Azumino-shi

Institute of Science Tokyo Hospital

Bunkyō City

Fukuoka Children's Hospital

Fukuoka

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 21, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions